Priority Date: 29.03.11 (EP 20110160275)

USE OF PHOSPHO-AKT AS A BIOMARKER OF DRUG RESPONSE

  • Application ID: EP12710755
  • Status: PATENT GRANTED

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
1 office
Technology Company
Employment test 11 - 50 employees
Company dna bohest ag
operating since 1888
826.07
Headquarter in Basel and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC combination C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) and G01 (MEASURING; TESTING) is specialized in the combination C12 and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Weidner Stern Jeschke, Zacco Denmark A/S, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB and 94 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 29.03.2011 - Priority Date (EP 20110160275)
  • 04.10.2012 - Publication A1 (WO2012130887)
  • 05.02.2014 - Publication A1 (EP2691533)
  • 05.04.2017 - Publication B1 (EP2691533)

IPC Classification